We've found
					11,964 Cardiology				
					clinical trials				
				
			
		
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Ischemia-Reperfusion Injury Clinical Trial
	Remote Ischemic Conditioning Using the autoRIC
		Status: Enrolling
  
							
  	
	Ischemia-Reperfusion Injury Clinical Trial
	Remote Ischemic Conditioning Using the autoRIC
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	Benefits of µCor in Ambulatory Decompensated Heart Failure
		Status: Enrolling
  
							
  	
	Heart Failure Clinical Trial
	Benefits of µCor in Ambulatory Decompensated Heart Failure
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	Benefits of µCor in Ambulatory Decompensated Heart Failure
		Status: Enrolling
  
							
  	
	Heart Failure Clinical Trial
	Benefits of µCor in Ambulatory Decompensated Heart Failure
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	ThRombosis ExclUsion STudy
		Status: Enrolling,
							Phase
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	ThRombosis ExclUsion STudy
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	Study of Dutogliptin in Combination With Filgrastim in Post-Myocardial Infarction
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	Study of Dutogliptin in Combination With Filgrastim in Post-Myocardial Infarction
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Congenital Heart Disease Clinical Trial
	Health Literacy in Adults
		Status: Enrolling,
							Phase
  
							
  	
	Congenital Heart Disease Clinical Trial
	Health Literacy in Adults
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 4/23/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	PARTNER 3 Trial - Mitral Valve in Valve
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	PARTNER 3 Trial - Mitral Valve in Valve
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Non-obstructive Hypertrophic Cardiomyopathy Clinical Trial
	A Phase 2 Study of Mavacamten in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Non-obstructive Hypertrophic Cardiomyopathy Clinical Trial
	A Phase 2 Study of Mavacamten in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Percutaneous Coronary Intervention Clinical Trial
	A Smartphone-based Application Post-myocardial Infarction to Manage Cardiovascular Disease Risk
		Status: Enrolling
  
							
  	
	Percutaneous Coronary Intervention Clinical Trial
	A Smartphone-based Application Post-myocardial Infarction to Manage Cardiovascular Disease Risk
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Coronary Artery Disease Clinical Trial
	Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Coronary Artery Disease Clinical Trial
	Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Coronary Artery Disease Clinical Trial
	Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Coronary Artery Disease Clinical Trial
	Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Coronary Artery Disease Clinical Trial
	Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Coronary Artery Disease Clinical Trial
	Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Coronary Artery Disease Clinical Trial
	Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Coronary Artery Disease Clinical Trial
	Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Dermatology / Plastic Surgery Clinical Trial
	Long-Term Study of EN3835 in Edematous Fibrosclerotic Panniculopathy (Cellulite)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Dermatology / Plastic Surgery Clinical Trial
	Long-Term Study of EN3835 in Edematous Fibrosclerotic Panniculopathy (Cellulite)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Dermatology / Plastic Surgery Clinical Trial
	Long-Term Study of EN3835 in Edematous Fibrosclerotic Panniculopathy (Cellulite)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Dermatology / Plastic Surgery Clinical Trial
	Long-Term Study of EN3835 in Edematous Fibrosclerotic Panniculopathy (Cellulite)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	Potassium Reduction Initiative to Optimize RAAS Inhibition Therapy With Sodium Zirconium Cyclosilicate in Heart Failure
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Heart Failure Clinical Trial
	Potassium Reduction Initiative to Optimize RAAS Inhibition Therapy With Sodium Zirconium Cyclosilicate in Heart Failure
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	Potassium Reduction Initiative to Optimize RAAS Inhibition Therapy With Sodium Zirconium Cyclosilicate in Heart Failure
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Heart Failure Clinical Trial
	Potassium Reduction Initiative to Optimize RAAS Inhibition Therapy With Sodium Zirconium Cyclosilicate in Heart Failure
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	TRANSFORM-HF: ToRsemide compArisoN With furoSemide FORManagement of Heart Failure
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	TRANSFORM-HF: ToRsemide compArisoN With furoSemide FORManagement of Heart Failure
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Patent Ductus Arteriosus Clinical Trial
	Acetaminophen vs Indomethacin in Treating hsPDA
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Patent Ductus Arteriosus Clinical Trial
	Acetaminophen vs Indomethacin in Treating hsPDA
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Obstructive Hypertrophic Cardiomyopathy Clinical Trial
	Clinical Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Obstructive Hypertrophic Cardiomyopathy Clinical Trial
	Clinical Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Chronic Heart Failure With Preserved Ejection Fraction Clinical Trial
	Patient-reported Outcomes in Vericiguat-treated Patients With HFpEF
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Chronic Heart Failure With Preserved Ejection Fraction Clinical Trial
	Patient-reported Outcomes in Vericiguat-treated Patients With HFpEF
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	VITROS Immunodiagnostic Products hs Troponin I
		Status: Enrolling,
							Phase
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	VITROS Immunodiagnostic Products hs Troponin I
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiac Surgery Clinical Trial
	QPI-1002 Phase 3 for Prevention of Major Adverse Kidney Events (MAKE) in Subjects at High Risk for AKI Following Cardiac Surgery
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiac Surgery Clinical Trial
	QPI-1002 Phase 3 for Prevention of Major Adverse Kidney Events (MAKE) in Subjects at High Risk for AKI Following Cardiac Surgery
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure-Type 2 Diabetes Mellitus Clinical Trial
	Effect of Sotagliflozin on Cardiovascular Events in Patients With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure-Type 2 Diabetes Mellitus Clinical Trial
	Effect of Sotagliflozin on Cardiovascular Events in Patients With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure-Type 2 Diabetes Mellitus Clinical Trial
	Effect of Sotagliflozin on Cardiovascular Events in Patients With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure-Type 2 Diabetes Mellitus Clinical Trial
	Effect of Sotagliflozin on Cardiovascular Events in Patients With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure-Type 2 Diabetes Mellitus Clinical Trial
	Effect of Sotagliflozin on Cardiovascular Events in Patients With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure-Type 2 Diabetes Mellitus Clinical Trial
	Effect of Sotagliflozin on Cardiovascular Events in Patients With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure-Type 2 Diabetes Mellitus Clinical Trial
	Effect of Sotagliflozin on Cardiovascular Events in Patients With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure-Type 2 Diabetes Mellitus Clinical Trial
	Effect of Sotagliflozin on Cardiovascular Events in Patients With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure-Type 2 Diabetes Mellitus Clinical Trial
	Effect of Sotagliflozin on Cardiovascular Events in Patients With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure-Type 2 Diabetes Mellitus Clinical Trial
	Effect of Sotagliflozin on Cardiovascular Events in Patients With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure With Preserved Ejection Fraction Clinical Trial
	Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure With Preserved Ejection Fraction Clinical Trial
	Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure With Preserved Ejection Fraction Clinical Trial
	Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure With Preserved Ejection Fraction Clinical Trial
	Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure With Preserved Ejection Fraction Clinical Trial
	Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure With Preserved Ejection Fraction Clinical Trial
	Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure With Preserved Ejection Fraction Clinical Trial
	Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure With Preserved Ejection Fraction Clinical Trial
	Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure With Preserved Ejection Fraction Clinical Trial
	Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure With Preserved Ejection Fraction Clinical Trial
	Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure With Preserved Ejection Fraction Clinical Trial
	Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure With Preserved Ejection Fraction Clinical Trial
	Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure With Preserved Ejection Fraction Clinical Trial
	Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure With Preserved Ejection Fraction Clinical Trial
	Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure With Preserved Ejection Fraction Clinical Trial
	Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure With Preserved Ejection Fraction Clinical Trial
	Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure With Preserved Ejection Fraction Clinical Trial
	Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure With Preserved Ejection Fraction Clinical Trial
	Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure With Preserved Ejection Fraction Clinical Trial
	Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure With Preserved Ejection Fraction Clinical Trial
	Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure With Preserved Ejection Fraction Clinical Trial
	Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure With Preserved Ejection Fraction Clinical Trial
	Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure With Preserved Ejection Fraction Clinical Trial
	Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure With Preserved Ejection Fraction Clinical Trial
	Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure With Preserved Ejection Fraction Clinical Trial
	Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure With Preserved Ejection Fraction Clinical Trial
	Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure With Preserved Ejection Fraction Clinical Trial
	Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure With Preserved Ejection Fraction Clinical Trial
	Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure With Preserved Ejection Fraction Clinical Trial
	Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure With Preserved Ejection Fraction Clinical Trial
	Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Diabetic Macular Edema Clinical Trial
	A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Diabetic Macular Edema Clinical Trial
	A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Diabetic Macular Edema Clinical Trial
	A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Diabetic Macular Edema Clinical Trial
	A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Diabetic Macular Edema Clinical Trial
	A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Diabetic Macular Edema Clinical Trial
	A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Diabetic Macular Edema Clinical Trial
	A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Diabetic Macular Edema Clinical Trial
	A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Diabetic Macular Edema Clinical Trial
	A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Diabetic Macular Edema Clinical Trial
	A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Diabetic Macular Edema Clinical Trial
	A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Diabetic Macular Edema Clinical Trial
	A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Diabetic Macular Edema Clinical Trial
	A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Diabetic Macular Edema Clinical Trial
	A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Diabetic Macular Edema Clinical Trial
	A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Diabetic Macular Edema Clinical Trial
	A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Diabetic Macular Edema Clinical Trial
	A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Diabetic Macular Edema Clinical Trial
	A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Diabetic Macular Edema Clinical Trial
	A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Diabetic Macular Edema Clinical Trial
	A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Diabetic Macular Edema Clinical Trial
	A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Diabetic Macular Edema Clinical Trial
	A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Diabetic Macular Edema Clinical Trial
	A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Diabetic Macular Edema Clinical Trial
	A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Diabetic Macular Edema Clinical Trial
	A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Diabetic Macular Edema Clinical Trial
	A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Diabetic Macular Edema Clinical Trial
	A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Diabetic Macular Edema Clinical Trial
	A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Diabetic Macular Edema Clinical Trial
	A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Diabetic Macular Edema Clinical Trial
	A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Endocrinology Clinical Trial
	Single and Multiple Ascending Doses of MEDI6570 in Subjects With Type 2 Diabetes Mellitus
		Status: Enrolling,
							Phase
													 I
  
							
  	
	Cardiology / Vascular Diseases, Endocrinology Clinical Trial
	Single and Multiple Ascending Doses of MEDI6570 in Subjects With Type 2 Diabetes Mellitus
		Status: Enrolling,
							Phase
													 I			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Endocrinology Clinical Trial
	Single and Multiple Ascending Doses of MEDI6570 in Subjects With Type 2 Diabetes Mellitus
		Status: Enrolling,
							Phase
													 I
  
							
  	
	Cardiology / Vascular Diseases, Endocrinology Clinical Trial
	Single and Multiple Ascending Doses of MEDI6570 in Subjects With Type 2 Diabetes Mellitus
		Status: Enrolling,
							Phase
													 I			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Endocrinology Clinical Trial
	Single and Multiple Ascending Doses of MEDI6570 in Subjects With Type 2 Diabetes Mellitus
		Status: Enrolling,
							Phase
													 I
  
							
  	
	Cardiology / Vascular Diseases, Endocrinology Clinical Trial
	Single and Multiple Ascending Doses of MEDI6570 in Subjects With Type 2 Diabetes Mellitus
		Status: Enrolling,
							Phase
													 I			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	ATrial Tachycardia PAcing Therapy in Congenital Heart
		Status: Enrolling,
							Phase
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	ATrial Tachycardia PAcing Therapy in Congenital Heart
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Paroxysmal Supraventricular Tachycardia Clinical Trial
	Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of PSVT. NODE-302
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Paroxysmal Supraventricular Tachycardia Clinical Trial
	Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of PSVT. NODE-302
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Other Clinical Trial
	Standardizing Emergency Work-ups Around Risk Data
		Status: Enrolling,
							Phase
  
							
  	
	Cardiology / Vascular Diseases, Other Clinical Trial
	Standardizing Emergency Work-ups Around Risk Data
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Other Clinical Trial
	Standardizing Emergency Work-ups Around Risk Data
		Status: Enrolling,
							Phase
  
							
  	
	Cardiology / Vascular Diseases, Other Clinical Trial
	Standardizing Emergency Work-ups Around Risk Data
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Other Clinical Trial
	Standardizing Emergency Work-ups Around Risk Data
		Status: Enrolling,
							Phase
  
							
  	
	Cardiology / Vascular Diseases, Other Clinical Trial
	Standardizing Emergency Work-ups Around Risk Data
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	Sorin Universal REgistry on Aortic Valve Replacement
		Status: Enrolling,
							Phase
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	Sorin Universal REgistry on Aortic Valve Replacement
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Critical Limb Ischemia Clinical Trial
	The DES BTK Vascular Stent System vs PTA in Subjects With Critical Limb Ischemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Critical Limb Ischemia Clinical Trial
	The DES BTK Vascular Stent System vs PTA in Subjects With Critical Limb Ischemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Critical Limb Ischemia Clinical Trial
	The DES BTK Vascular Stent System vs PTA in Subjects With Critical Limb Ischemia
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Critical Limb Ischemia Clinical Trial
	The DES BTK Vascular Stent System vs PTA in Subjects With Critical Limb Ischemia
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Critical Limb Ischemia Clinical Trial
	Blood Derived Autologous Angiogenic Cell Precursor Therapy in Patients With Critical Limb Ischemia (ACP-CLI)
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Critical Limb Ischemia Clinical Trial
	Blood Derived Autologous Angiogenic Cell Precursor Therapy in Patients With Critical Limb Ischemia (ACP-CLI)
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Critical Limb Ischemia Clinical Trial
	Blood Derived Autologous Angiogenic Cell Precursor Therapy in Patients With Critical Limb Ischemia (ACP-CLI)
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Critical Limb Ischemia Clinical Trial
	Blood Derived Autologous Angiogenic Cell Precursor Therapy in Patients With Critical Limb Ischemia (ACP-CLI)
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Aneurysms Clinical Trial
	A Study to Look at Performance of MICRUSFRAME and GALAXY Coils for the Treatment of Intracranial Aneurysms
		Status: Enrolling
  
							
  	
	Aneurysms Clinical Trial
	A Study to Look at Performance of MICRUSFRAME and GALAXY Coils for the Treatment of Intracranial Aneurysms
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Other Clinical Trial
	National Cardiogenic Shock Initiative
		Status: Enrolling,
							Phase
  
							
  	
	Cardiology / Vascular Diseases, Other Clinical Trial
	National Cardiogenic Shock Initiative
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Other Clinical Trial
	National Cardiogenic Shock Initiative
		Status: Enrolling,
							Phase
  
							
  	
	Cardiology / Vascular Diseases, Other Clinical Trial
	National Cardiogenic Shock Initiative
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Other Clinical Trial
	National Cardiogenic Shock Initiative
		Status: Enrolling,
							Phase
  
							
  	
	Cardiology / Vascular Diseases, Other Clinical Trial
	National Cardiogenic Shock Initiative
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Other Clinical Trial
	National Cardiogenic Shock Initiative
		Status: Enrolling,
							Phase
  
							
  	
	Cardiology / Vascular Diseases, Other Clinical Trial
	National Cardiogenic Shock Initiative
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Endocrinology Clinical Trial
	Effect of Daily Steps on Fat Metabolism
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases, Endocrinology Clinical Trial
	Effect of Daily Steps on Fat Metabolism
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Neurology Clinical Trial
	Stroke and Cerebrovascular Diseases Registry
		Status: Enrolling,
							Phase
  
							
  	
	Cardiology / Vascular Diseases, Neurology Clinical Trial
	Stroke and Cerebrovascular Diseases Registry
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	An Early Feasibility Evaluation of the AccuCinch® Ventricular Repair System in Patients With Heart Failure and Reduced Ejection Fraction (HFrEF) - The CorCinch-HFrEF Study
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	An Early Feasibility Evaluation of the AccuCinch® Ventricular Repair System in Patients With Heart Failure and Reduced Ejection Fraction (HFrEF) - The CorCinch-HFrEF Study
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Neurology, Psychiatry / Psychology Clinical Trial
	Alzheimer's Autism and Cognitive Impairment Stem Cell Treatment Study
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases, Neurology, Psychiatry / Psychology Clinical Trial
	Alzheimer's Autism and Cognitive Impairment Stem Cell Treatment Study
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Coronary Artery Disease (CAD) Clinical Trial
	Imaging of Coronary Plaques in Subjects Treated With Evolocumab
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Coronary Artery Disease (CAD) Clinical Trial
	Imaging of Coronary Plaques in Subjects Treated With Evolocumab
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Coronary Artery Disease (CAD) Clinical Trial
	Imaging of Coronary Plaques in Subjects Treated With Evolocumab
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Coronary Artery Disease (CAD) Clinical Trial
	Imaging of Coronary Plaques in Subjects Treated With Evolocumab
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiac Disease Clinical Trial
	DEF-314 Better Accuracy in EF Assessment With DEFINITY
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiac Disease Clinical Trial
	DEF-314 Better Accuracy in EF Assessment With DEFINITY
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Click here to add this to my saved trials
  
							
  
  
  
  
			Click here to add this to my saved trials
	    
	 Click here to add this to my saved trials
  
							
  
  
  
  
			Click here to add this to my saved trials
	    
	 Click here to add this to my saved trials
  
							
  
  
  
  
			Click here to add this to my saved trials
	    
	 Click here to add this to my saved trials
  
							
  
  
  
  
			Click here to add this to my saved trials
	    
	 Click here to add this to my saved trials
  
							
  
  
  
  
			Click here to add this to my saved trials
	    
	 Click here to add this to my saved trials
  
							
  
  
  
  
			Click here to add this to my saved trials
	    
	 
  
						
				
			
We've found
					11,964 Cardiology
				
					clinical trials
				
				
				
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Ischemia-Reperfusion Injury Clinical Trial
	
Updated: 12/31/1969
  
  
  Remote Ischemic Conditioning Using the autoRIC
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  Benefits of µCor in Ambulatory Decompensated Heart Failure
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  Benefits of µCor in Ambulatory Decompensated Heart Failure
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  ThRombosis ExclUsion STudy
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  Study of Dutogliptin in Combination With Filgrastim in Post-Myocardial Infarction
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Congenital Heart Disease Clinical Trial
	
Updated: 4/23/2018
  
  
  Health Literacy in Adults
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 4/23/2018
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  PARTNER 3 Trial - Mitral Valve in Valve
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Non-obstructive Hypertrophic Cardiomyopathy Clinical Trial
	
Updated: 12/31/1969
  
  
  A Phase 2 Study of Mavacamten in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Percutaneous Coronary Intervention Clinical Trial
	
Updated: 12/31/1969
  
  
  A Smartphone-based Application Post-myocardial Infarction to Manage Cardiovascular Disease Risk
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Coronary Artery Disease Clinical Trial
	
Updated: 12/31/1969
  
  
  Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Coronary Artery Disease Clinical Trial
	
Updated: 12/31/1969
  
  
  Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Coronary Artery Disease Clinical Trial
	
Updated: 12/31/1969
  
  
  Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Coronary Artery Disease Clinical Trial
	
Updated: 12/31/1969
  
  
  Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Dermatology / Plastic Surgery Clinical Trial
	
Updated: 12/31/1969
  
  
  Long-Term Study of EN3835 in Edematous Fibrosclerotic Panniculopathy (Cellulite)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Dermatology / Plastic Surgery Clinical Trial
	
Updated: 12/31/1969
  
  
  Long-Term Study of EN3835 in Edematous Fibrosclerotic Panniculopathy (Cellulite)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  Potassium Reduction Initiative to Optimize RAAS Inhibition Therapy With Sodium Zirconium Cyclosilicate in Heart Failure
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  Potassium Reduction Initiative to Optimize RAAS Inhibition Therapy With Sodium Zirconium Cyclosilicate in Heart Failure
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  TRANSFORM-HF: ToRsemide compArisoN With furoSemide FORManagement of Heart Failure
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Patent Ductus Arteriosus Clinical Trial
	
Updated: 12/31/1969
  
  
  Acetaminophen vs Indomethacin in Treating hsPDA
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Obstructive Hypertrophic Cardiomyopathy Clinical Trial
	
Updated: 12/31/1969
  
  
  Clinical Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Chronic Heart Failure With Preserved Ejection Fraction Clinical Trial
	
Updated: 12/31/1969
  
  
  Patient-reported Outcomes in Vericiguat-treated Patients With HFpEF
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  VITROS Immunodiagnostic Products hs Troponin I
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiac Surgery Clinical Trial
	
Updated: 12/31/1969
  
  
  QPI-1002 Phase 3 for Prevention of Major Adverse Kidney Events (MAKE) in Subjects at High Risk for AKI Following Cardiac Surgery
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure-Type 2 Diabetes Mellitus Clinical Trial
	
Updated: 12/31/1969
  
  
  Effect of Sotagliflozin on Cardiovascular Events in Patients With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure-Type 2 Diabetes Mellitus Clinical Trial
	
Updated: 12/31/1969
  
  
  Effect of Sotagliflozin on Cardiovascular Events in Patients With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure-Type 2 Diabetes Mellitus Clinical Trial
	
Updated: 12/31/1969
  
  
  Effect of Sotagliflozin on Cardiovascular Events in Patients With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure-Type 2 Diabetes Mellitus Clinical Trial
	
Updated: 12/31/1969
  
  
  Effect of Sotagliflozin on Cardiovascular Events in Patients With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure-Type 2 Diabetes Mellitus Clinical Trial
	
Updated: 12/31/1969
  
  
  Effect of Sotagliflozin on Cardiovascular Events in Patients With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure With Preserved Ejection Fraction Clinical Trial
	
Updated: 12/31/1969
  
  
  Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure With Preserved Ejection Fraction Clinical Trial
	
Updated: 12/31/1969
  
  
  Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure With Preserved Ejection Fraction Clinical Trial
	
Updated: 12/31/1969
  
  
  Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure With Preserved Ejection Fraction Clinical Trial
	
Updated: 12/31/1969
  
  
  Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure With Preserved Ejection Fraction Clinical Trial
	
Updated: 12/31/1969
  
  
  Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure With Preserved Ejection Fraction Clinical Trial
	
Updated: 12/31/1969
  
  
  Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure With Preserved Ejection Fraction Clinical Trial
	
Updated: 12/31/1969
  
  
  Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure With Preserved Ejection Fraction Clinical Trial
	
Updated: 12/31/1969
  
  
  Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure With Preserved Ejection Fraction Clinical Trial
	
Updated: 12/31/1969
  
  
  Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure With Preserved Ejection Fraction Clinical Trial
	
Updated: 12/31/1969
  
  
  Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure With Preserved Ejection Fraction Clinical Trial
	
Updated: 12/31/1969
  
  
  Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure With Preserved Ejection Fraction Clinical Trial
	
Updated: 12/31/1969
  
  
  Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure With Preserved Ejection Fraction Clinical Trial
	
Updated: 12/31/1969
  
  
  Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure With Preserved Ejection Fraction Clinical Trial
	
Updated: 12/31/1969
  
  
  Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure With Preserved Ejection Fraction Clinical Trial
	
Updated: 12/31/1969
  
  
  Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Diabetic Macular Edema Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Diabetic Macular Edema Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Diabetic Macular Edema Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Diabetic Macular Edema Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Diabetic Macular Edema Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Diabetic Macular Edema Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Diabetic Macular Edema Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Diabetic Macular Edema Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Diabetic Macular Edema Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Diabetic Macular Edema Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Diabetic Macular Edema Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Diabetic Macular Edema Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Diabetic Macular Edema Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Diabetic Macular Edema Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Diabetic Macular Edema Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Endocrinology Clinical Trial
	
Updated: 12/31/1969
  
  
  Single and Multiple Ascending Doses of MEDI6570 in Subjects With Type 2 Diabetes Mellitus
		Status: Enrolling,
							Phase
													 I			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Endocrinology Clinical Trial
	
Updated: 12/31/1969
  
  
  Single and Multiple Ascending Doses of MEDI6570 in Subjects With Type 2 Diabetes Mellitus
		Status: Enrolling,
							Phase
													 I			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Endocrinology Clinical Trial
	
Updated: 12/31/1969
  
  
  Single and Multiple Ascending Doses of MEDI6570 in Subjects With Type 2 Diabetes Mellitus
		Status: Enrolling,
							Phase
													 I			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  ATrial Tachycardia PAcing Therapy in Congenital Heart
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Paroxysmal Supraventricular Tachycardia Clinical Trial
	
Updated: 12/31/1969
  
  
  Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of PSVT. NODE-302
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Other Clinical Trial
	
Updated: 12/31/1969
  
  
  Standardizing Emergency Work-ups Around Risk Data
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Other Clinical Trial
	
Updated: 12/31/1969
  
  
  Standardizing Emergency Work-ups Around Risk Data
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Other Clinical Trial
	
Updated: 12/31/1969
  
  
  Standardizing Emergency Work-ups Around Risk Data
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  Sorin Universal REgistry on Aortic Valve Replacement
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Critical Limb Ischemia Clinical Trial
	
Updated: 12/31/1969
  
  
  The DES BTK Vascular Stent System vs PTA in Subjects With Critical Limb Ischemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Critical Limb Ischemia Clinical Trial
	
Updated: 12/31/1969
  
  
  The DES BTK Vascular Stent System vs PTA in Subjects With Critical Limb Ischemia
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Critical Limb Ischemia Clinical Trial
	
Updated: 12/31/1969
  
  
  Blood Derived Autologous Angiogenic Cell Precursor Therapy in Patients With Critical Limb Ischemia (ACP-CLI)
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Critical Limb Ischemia Clinical Trial
	
Updated: 12/31/1969
  
  
  Blood Derived Autologous Angiogenic Cell Precursor Therapy in Patients With Critical Limb Ischemia (ACP-CLI)
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Aneurysms Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study to Look at Performance of MICRUSFRAME and GALAXY Coils for the Treatment of Intracranial Aneurysms
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Other Clinical Trial
	
Updated: 12/31/1969
  
  
  National Cardiogenic Shock Initiative
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Other Clinical Trial
	
Updated: 12/31/1969
  
  
  National Cardiogenic Shock Initiative
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Other Clinical Trial
	
Updated: 12/31/1969
  
  
  National Cardiogenic Shock Initiative
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Other Clinical Trial
	
Updated: 12/31/1969
  
  
  National Cardiogenic Shock Initiative
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Endocrinology Clinical Trial
	
Updated: 12/31/1969
  
  
  Effect of Daily Steps on Fat Metabolism
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Neurology Clinical Trial
	
Updated: 12/31/1969
  
  
  Stroke and Cerebrovascular Diseases Registry
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  An Early Feasibility Evaluation of the AccuCinch® Ventricular Repair System in Patients With Heart Failure and Reduced Ejection Fraction (HFrEF) - The CorCinch-HFrEF Study
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Neurology, Psychiatry / Psychology Clinical Trial
	
Updated: 12/31/1969
  
  
  Alzheimer's Autism and Cognitive Impairment Stem Cell Treatment Study
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Coronary Artery Disease (CAD) Clinical Trial
	
Updated: 12/31/1969
  
  
  Imaging of Coronary Plaques in Subjects Treated With Evolocumab
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Coronary Artery Disease (CAD) Clinical Trial
	
Updated: 12/31/1969
  
  
  Imaging of Coronary Plaques in Subjects Treated With Evolocumab
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiac Disease Clinical Trial
	
Updated: 12/31/1969
  
  
  DEF-314 Better Accuracy in EF Assessment With DEFINITY
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  Click here to add this to my saved trials
	    
	 
  Click here to add this to my saved trials
	    
	 
  Click here to add this to my saved trials
	    
	 
  Click here to add this to my saved trials
	    
	 
  Click here to add this to my saved trials
	    
	 
  Click here to add this to my saved trials
	    
	